Suppr超能文献

使用HeRO装置维持下肢通路。

Maintaining lower limb access with the HeRO device.

作者信息

Madurska Marta J, Kingsmore David B, Stevenson Karen S, Thomson Peter, Kasthuri Ram

机构信息

Department of Vascular Surgery, Queen Elizabeth University Hospital, Marton Rd, Middlesbrough, Glasgow, TS4 3BW, UK.

Department of Transplant and Vascular Surgery, Queen Elizabeth University Hospital, Glasgow, UK.

出版信息

J Artif Organs. 2019 Jun;22(2):141-145. doi: 10.1007/s10047-018-1079-5. Epub 2018 Nov 7.

Abstract

Central venous catheters (CVC) remain a mainstay of vascular access particularly for incident patients,
but lead to central vein stenosis (CVS) in up to 1 in 6 patents. This often leads to establishing dialysis access in the groin which in turn may result in development of CVS in the lower body, although this is poorly reported. The HeRO device was designed to address CVS by bypassing the stenosed veins with a nitinol-reinforced silicone tube into the right atrium, which acts as an outflow conduit attached to an arterial inflow. The efficacy and safety of the HeRO device in the upper limb is well established, but there is no data on its use in the lower limb. We describe 2 cases of HeRO in the lower limb, one primary and one secondary, which remain in use. Lower limb HeRO is feasible in the lower limb and can work well either as de novo (to achieve vascular access) or as a salvage procedure (to maintain vascular access).

摘要

中心静脉导管(CVC)仍然是血管通路的主要方式,尤其是对于初发患者,但在多达六分之一的患者中会导致中心静脉狭窄(CVS)。这通常会导致在腹股沟建立透析通路,进而可能导致下半身出现CVS,尽管这方面的报道很少。HeRO装置的设计目的是通过用镍钛诺增强硅胶管绕过狭窄静脉进入右心房来解决CVS问题,右心房作为连接动脉流入的流出管道。HeRO装置在上肢的有效性和安全性已得到充分证实,但尚无其在下肢使用的数据。我们描述了2例下肢使用HeRO装置的病例,1例为原发性,1例为继发性,目前仍在使用。下肢HeRO装置在下肢是可行的,无论是作为初次使用(以实现血管通路)还是作为挽救手术(以维持血管通路)都能很好地发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验